Immuron Limited (ASX:IMC)
0.0370
0.00 (0.00%)
Nov 20, 2026, 3:01 PM AEDT
Immuron Market Cap
Immuron has a market cap or net worth of 11.95 million as of November 19, 2026. It is the 42,423rd most valuable company in the world and the 1,226th biggest in Australia. Its market cap has decreased by 30.66% in one year.
Market Cap
11.95M
Enterprise Value
3.12M
Revenue
7.71M
Global Rank
Country Rank
#1,226 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 11.95M, a decrease of -67.98%. That is a compound annual growth rate of -4.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 11.95M | 1.94% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 16.22M |
| Proteomics International Laboratories | 15.38M |
| Imugene | 15.18M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 13.65M |
| Radiopharm Theranostics | 13.01M |
| Patrys | 12.81M |
| ReNerve | 12.06M |